Hundreds of patients to get life-extending lung cancer drug on the NHS

NHS England

13 May 2022 - Hundreds of people with a form of the most common form of lung cancer could survive twice as long with the disease, thanks to a drug now available on the NHS.

The drug, durvalumab, can double the overall time someone can survive with an aggressive form of lung cancer from two and a half to five years.

Read NHS England press release

Michael Wonder

Posted by:

Michael Wonder